PA
Prakhar Agrawal Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
11
Avg Return
Past Year
Past Year
49%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.3%
Neutral
7.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| – | – | 1 | -9.5% |
0
%
| 1 Dec ‘25 1 month ago |
|
|
|
Overweight
Upgraded
| – | – | 1 | +17% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| – | – | 2 | +58% |
0
%
| 3 Sep ‘25 4 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +89% |
0
%
| 15 Aug ‘25 4 months ago |
|
|
|
Overweight
Reiterated
| $65 |
5%
downside
| 1 | +214% |
0
%
| 23 Jun ‘25 6 months ago |
|
|
|
Overweight
Reiterated
| – | – | 2 | +11% |
0
%
| 6 May ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| – | – | 3 | +28% |
0
%
| 23 Apr ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | +70% |
0
%
| 18 Mar ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | -80% |
–
| 21 Jan ‘25 11 months ago |
|